Oncotarget

Corrections:

Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment

PDF  |  How to cite

Oncotarget. 2018; 9:28797-28797. https://doi.org/10.18632/oncotarget.25683

Metrics: PDF 503 views  |   ?  

Hajer Ziouziou1,2,3,4,7, Claudia Andrieu1,2,3,4, Erik Laurini5,6, Sara Karaki1,2,3,4, Maurizio Fermeglia5,6, Ridha Oueslati7, David Taieb1,2,3,4, Michel Camplo6, Olivier Siri8, Sabrina Pricl5,6, Maria Katsogiannou1,2,3,4 and Palma Rocchi1,2,3,4

1Inserm, UMR1068, CRCM, Marseille, France
2Institut Paoli-Calmettes, Marseille, France
3Aix-Marseille Université, Marseille, France
4CNRS, UMR7258, CRCM, Marseille, France
5Molecular Simulation Engineering (MOSE) Laboratory, DEA, University of Trieste, Trieste, Italy
6National Interuniversity Consortium for Material Science and Technology (INSTM), Research Unit MOSE-DEA, University of Trieste, Trieste, Italy
7Unit of Immunology Microbiology Environmental and Carcinogenesis (IMEC), Science Faculty of Bizerte, University of Carthage, Bizerte, Tunisia
8Aix-Marseille Université, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille, UMR 7325, Marseille, France

Published: June 19, 2018

This article has been corrected: The proper listing of author names is given below:

Hajer Ziouziou1,2,3,4,7, Claudia Andrieu1,2,3,4, Erik Laurini5,6, Sara Karaki1,2,3,4, Maurizio Fermeglia5,6, Ridha Oueslati7, David Taieb1,2,3,4, Michel Camplo6, Olivier Siri8, Sabrina Pricl5,6, Maria Katsogiannou1,2,3,4 and Palma Rocchi1,2,3,4

Original article: 2017; 8:77317-77329. DOI: https://doi.org/10.18632/oncotarget.20469.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25683